A detailed history of Captrust Financial Advisors transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 13,140 shares of ARMP stock, worth $25,623. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,140
Previous 13,140 -0.0%
Holding current value
$25,623
Previous $36,000 13.89%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$2.81 - $4.18 $1,146 - $1,705
-408 Reduced 3.01%
13,140 $54,000
Q1 2023

May 15, 2023

BUY
$1.1 - $3.58 $14,902 - $48,501
13,548 New
13,548 $22,000
Q1 2022

May 16, 2022

BUY
$3.9 - $6.32 $1,591 - $2,578
408 New
408 $2,000

Others Institutions Holding ARMP

About Armata Pharmaceuticals, Inc.


  • Ticker ARMP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,144,700
  • Market Cap $70.5M
  • Description
  • Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...
More about ARMP
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.